Generation of fibroblasts overexpressing liver-specific PEPCK in a miniature pig model of human type 2 diabetes mellitus

Molecular Medicine Reports

Volumn 6, Issue 1, 2012, Pages 45-50

  Kim, Yu Kyung ^a   Lee, Geun Shik ^b   Jung, Eui Man ^c   Hyun, Sang Hwan ^c   Hwang, Woo Suk ^a   Jeung, Eui Bae ^c  

^a SooAm Biotech Research Foundation   (South Korea)

^b Kangwon National University   (South Korea)

^c Chungbuk National University   (South Korea)

Author keywords

Diabetes mellitus; Liver specific expression; Miniature pig; Phosphoenolpyruvate carboxykinase

Indexed keywords

BETA GALACTOSIDASE; DEXAMETHASONE; GLUCOCORTICOID; GREEN FLUORESCENT PROTEIN; LIPOSOME; LUCIFERASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; GENE ACTIVITY; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; SWINE; TRANSGENE;

ANIMALS; CELL LINE; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE EXPRESSION; GENE ORDER; GENE TARGETING; HUMANS; LIVER; ORGAN SPECIFICITY; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PROMOTER REGIONS, GENETIC; SWINE; TRANSFECTION;

ANIMALIA; SUIDAE; SUS;

EID: 84861651691     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.873     Document Type: Article

References (28)

1. Holt RIG: Textbook of Diabetes. Wiley-Blackwell, Chichester, West Sussex, 2010.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998.
3. Maggs DG, Buchanan TA, Burant CF, et al: Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 128: 176-185, 1998. (Pubitemid 28078198)
4. Gastaldelli A, Miyazaki Y, Pettiti M, et al: Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J Clin Endocrinol Metab 89: 3914-3921, 2004. (Pubitemid 39071494)
5. Magnusson I, Rothman DL, Katz LD, Shulman RG and Shulman GI: Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327, 1992.
6. Wajngot A, Chandramouli V, Schumann WC, et al: Quantitative contributions of gluconeogenesis to glucose production during fasting in type 2 diabetes mellitus. Metabolism 50: 47-52, 2001. (Pubitemid 32058548)
7. Kunert O, Stingl H, Rosian E, et al: Measurement of fractional whole-body gluconeogenesis in humans from blood samples using 2H nuclear magnetic resonance spectroscopy. Diabetes 52: 2475-2482, 2003. (Pubitemid 37210534)
8. Pilkis SJ and Granner DK: Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis. Annu Rev Physiol 54: 885-909, 1992.
9. Hanson RW and Garber AJ: Phosphoenolpyruvate carboxykinase. I. Its role in gluconeogenesis. Am J Clin Nutr 25: 1010-1021, 1972.
10. Du K, Herzig S, Kulkarni RN and Montminy M: TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300: 1574-1577, 2003. (Pubitemid 36682889)
11. Jurado LA, Song S, Roesler WJ and Park EA: Conserved amino acids within CCAAT enhancer-binding proteins (C/EBP(alpha) and beta) regulate phosphoenolpyruvate carboxykinase (PEPCK) gene expression. J Biol Chem 277: 27606-27612, 2002. (Pubitemid 34966702)
12. Nakae J, Kitamura T, Silver DL and Accili D: The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108: 1359-1367, 2001. (Pubitemid 33107764)
13. Veneziale CM, Donofrio JC and Nishimura H: The concentration of P-enolpyruvate carboxykinase protein in murine tissues in diabetes of chemical and genetic origin. J Biol Chem 258: 14257-14262, 1983. (Pubitemid 14217945)
14. Valera A, Pujol A, Pelegrin M and Bosch F: Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 9151-9154, 1994.
15. Short JM, Wynshaw-Boris A, Short HP and Hanson RW: Characterization of the phosphoenolpyruvate carboxykinase (GTP) promoter-regulatory region. II. Identification of cAMP and glucocorticoid regulatory domains. J Biol Chem 261: 9721-9726, 1986. (Pubitemid 17214099)
16. Gock H, Nottle M, Lew AM, d'Apice AJ and Cowan P: Genetic modification of pigs for solid organ xenotransplantation. Transplant Rev (Orlando) 25: 9-20, 2011.
17. Zhao J, Whyte J and Prather RS: Effect of epigenetic regulation during swine embryogenesis and on cloning by nuclear transfer. Cell Tissue Res 341: 13-21, 2010.
18. Dinnyes A, De Sousa P, King T and Wilmut I: Somatic cell nuclear transfer: recent progress and challenges. Cloning Stem Cells 4: 81-90, 2002. (Pubitemid 34437642)
19. Friedman JE: Role of glucocorticoids in activation of hepatic PEPCK gene transcription during exercise. Am J Physiol 266: E560-E566, 1994.
20. Roesler WJ, Simard J, Graham JG and McFie PJ: Characterization of the liver-specific component of the cAMP response unit in the phosphoenolpyruvate carboxykinase (GTP) gene promoter. J Biol Chem 269: 14276-14283, 1994. (Pubitemid 24191190)
21. Liu JS, Park EA, Gurney AL, Roesler WJ and Hanson RW: Cyclic AMP induction of phosphoenolpyruvate carboxykinase (GTP) gene transcription is mediated by multiple promoter elements. J Biol Chem 266: 19095-19102, 1991. (Pubitemid 21908197)
22. Roesler WJ, Vandenbark GR and Hanson RW: Identification of multiple protein binding domains in the promoter-regulatory region of the phosphoenolpyruvate carboxykinase (GTP) gene. J Biol Chem 264: 9657-9664, 1989. (Pubitemid 19157614)
23. Lee GS, Hyun SH, Kim HS, et al: Improvement of a porcine somatic cell nuclear transfer technique by optimizing donor cell and recipient oocyte preparations. Theriogenology 59: 1949-1957, 2003.
24. Yamazaki Y, Makino H, Hamaguchi-Hamada K, et al: Assessment of the developmental totipotency of neural cells in the cerebral cortex of mouse embryo by nuclear transfer. Proc Natl Acad Sci USA 98: 14022-14026, 2001. (Pubitemid 33116017)
25. Hanson RW and Reshef L: Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 66: 581-611, 1997. (Pubitemid 27274668)
26. Sun Y, Liu S, Ferguson S, et al: Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277: 23301-23307, 2002. (Pubitemid 34952159)
27. She P, Shiota M, Shelton KD, Chalkley R, Postic C and Magnuson MA: Phosphoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 20: 6508-6517, 2000. (Pubitemid 30650237)
28. Petersen B, Carnwath JW and Niemann H: The perspectives for porcine-to-human xenografts. Comp Immunol Microbiol Infect Dis 32: 91-105, 2009.